Using BRET to Detect Ligand-Specific Conformational Changes in Preformed Signalling Complexes

Methods in Molecular Biology

Volumn 756, Issue , 2011, Pages 149-163

  Audet, Nicolas ^a,b   Piñeyro, Graciela ^a,b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Bioluminescence resonance energy transfer; G protein coupled receptor; Heterotrimeric guanine nucleotide binding protein; Protein complex; Signal transduction

Indexed keywords

HETEROTRIMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; LIGAND;

ANIMAL; ARTICLE; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CELL LINE; CHEMISTRY; HUMAN; METABOLISM; METHODOLOGY; PROTEIN CONFORMATION; SIGNAL TRANSDUCTION;

ANIMALS; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER TECHNIQUES; CELL LINE; HETEROTRIMERIC GTP-BINDING PROTEINS; HUMANS; LIGANDS; PROTEIN CONFORMATION; SIGNAL TRANSDUCTION;

EID: 80054769792     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61779-160-4_7     Document Type: Chapter

References (32)

1. Yao, X., Parnot, C., Deupi, X., Ratnala, V. R., Swaminath, G., Farrens, D., and Kobilka, B. (2006) Coupling ligand structure to specific conformational switches in the beta2-adrenoceptor. Nat Chem Biol 2, 417–22.
2. Granier, S., Kim, S., Shafer, A. M., Ratnala, V. R., Fung, J. J., Zare, R. N., and Kobilka, B. (2007) Structure and conformational changes in the C-terminal domain of the beta2-adrenoceptor: insights from fluorescence resonance energy transfer studies. J Biol Chem 282, 13895–905.
3. Oldham, W. M., and Hamm, H. E. (2008) Heterotrimeric G protein activation by G-protein-coupled receptors. Nat Rev Mol Cell Biol 9, 60–71.
4. Kapoor, N., Menon, S. T., Chauhan, R., Sachdev, P., and Sakmar, T. P. (2009) Structural evidence for a sequential release mechanism for activation of heterotrimeric G proteins. J Mol Biol 393, 882–97.
5. Brinkerhoff, C. J., Traynor, J. R., and Linderman, J. J. (2008) Collision coupling, crosstalk, and compartmentalization in G-protein coupled receptor systems: can a single model explain disparate results? J Theor Biol 255, 278–86.
6. Hein, P., and Bunemann, M. (2009) Coupling mode of receptors and G proteins. Naunyn Schmiedebergs Arch Pharmacol 379, 435–43.
7. Citri, Y., and Schramm, M. (1980) Resolution, reconstitution and kinetics of the primary action of a hormone receptor. Nature 287, 297–300.
8. Hebert, T. E., Gales, C., and Rebois, R. V. (2006) Detecting and imaging protein-protein interactions during G protein-mediated signal transduction in vivo and in situ by using fluorescence-based techniques. Cell Biochem Biophys 45, 85–109.
9. Lohse, M. J., Nikolaev, V. O., Hein, P., Hoffmann, C., Vilardaga, J. P., and Bünemann, M. (2008) Optical techniques to analyze real-time activation and signaling of G-protein-coupled receptors. Trends Pharmacol Sci 29, 159–65.
10. Pineyro, G. (2009) Membrane signalling complexes: implications for development of functionally selective ligands modulating heptahelical receptor signalling. Cell Signal 21, 179–85.
11. Galés, C., Rebois, R. V., Hogue, M., Trieu, P., Breit, A., Hébert, T. E., and Bouvier, M. (2005) Real-time monitoring of receptor and G-protein interactions in living cells. Nat Methods 2, 177–84.
12. Rebois, R. V., Robitaille, M., Galés, C., Dupré, D. J., Baragli, A., Trieu, P., Ethier, N., Bouvier, M., and Hébert, T. E. (2006) Heterotrimeric G proteins form stable complexes with adenylyl cyclase and Kir3.1 channels in living cells. J Cell Sci 119, 2807–18.
13. Audet, N., Galés, C., Archer-Lahlou, E., Vallières, M., Schiller, P. W., Bouvier, M., and Pineyro, G. (2008) Bioluminescence resonance energy transfer assays reveal ligand-specific conformational changes within preformed signaling complexes containing delta-opioid receptors and heterotrimeric G proteins. J Biol Chem 283, 15078–88.
14. Angers, S., Salahpour, A., Joly, E., Hilairet, S., Chelsky, D., Dennis, M., and Bouvier, M. (2000) Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proc Natl Acad Sci U S A 97, 3684–9.
15. Milligan, G., and Bouvier, M. (2005) Methods to monitor the quaternary structure of G protein-coupled receptors. Febs J 272, 2914–25.
16. Marullo, S., and Bouvier, M. (2007) Resonance energy transfer approaches in molecular pharmacology and beyond. Trends Pharmacol Sci 28, 362–5.
17. Bouvier, M., Heveker, N., Jockers, R., Marullo, S., and Milligan, G. (2007) BRET analysis of GPCR oligomerization: newer does not mean better. Nat Methods 4, 3–4; author reply 4.
18. Salahpour, A., and Masri, B. (2007) Experimental challenge to a ‘rigorous’ BRET analysis of GPCR oligomerization. Nat Methods 4, 599–600; author reply 601.
19. Maehle, A. H. (2005) The quantification and differentiation of the drug receptor theory, c. 1910–1960. Ann Sci 62, 479–500.
20. Colquhoun, D. (2006) The quantitative analysis of drug-receptor interactions: a short history. Trends Pharmacol Sci 27, 149–57.
21. Roettger, B. F., Ghanekar, D., Rao, R., Toledo, C., Yingling, J., Pinon, D., and Miller, L. J. (1997) Antagonist-stimulated internalization of the G protein-coupled cholecystokinin receptor. Mol Pharmacol 51, 357–62.
22. Willins, D. L., and Meltzer, H. Y. (1998) Serotonin 5-HT2C agonists selectively inhibit morphine-induced dopamine efflux in the nucleus accumbens. Brain Res 781, 291–9.
23. Azzi, M., Charest, P. G., Angers, S., Rousseau, G., Kohout, T., Bouvier, M., and Piñeyro, G. (2003) Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors. Proc Natl Acad Sci U S A 100, 11406–11.
24. Audet, N., Paquin-Gobeil, M., Landry-Paquet, O., Schiller, P. W., and Pineyro, G. (2005) Internalization and Src activity regulate the time course of ERK activation by delta opioid receptor ligands. J Biol Chem 280, 7808–16.
25. Groer, C. E., Tidgewell, K., Moyer, R. A., Harding, W. W., Rothman, R. B., Prisinzano, T. E., and Bohn, L. M. (2007) An opioid agonist that does not induce micro-opioid receptor--arrestin interactions or receptor internalization. Mol Pharmacol 71, 549–57.
26. Urban, J. D., Clarke, W. P., von Zastrow, M., Nichols, D. E., Kobilka, B., Weinstein, H., Javitch, J. A., Roth, B. L., Christopoulos, A., Sexton, P. M., Miller, K. J., Spedding, M., and Mailman, R. B. (2007) Functional selectivity and classical concepts of quantitative pharmacology. J Pharmacol Exp Ther 320, 1–13.
27. Ehlert, F. J. (2008) On the analysis of ligand-directed signaling at G protein-coupled receptors. Naunyn Schmiedebergs Arch Pharmacol 377, 549–77.
28. Kenakin, T. (2005) New concepts in drug discovery: collateral efficacy and permissive antagonism. Nat Rev Drug Discov 4, 919–27.
29. Kenakin, T. (2007) Functional selectivity through protean and biased agonism: who steers the ship? Mol Pharmacol 72, 1393–401.
30. Pfleger, K. D., Seeber, R. M., and Eidne, K. A. (2006) Bioluminescence resonance energy transfer (BRET) for the real-time detection of protein-protein interactions. Nat Protoc 1, 337–45.
31. Loening, A. M., Fenn, T. D., Wu, A. M., and Gambhir, S. S. (2006) Consensus guided mutagenesis of Renilla luciferase yields enhanced stability and light output. Protein Eng Des Sel 19, 391–400.
32. Kocan, M., See, H. B., Seeber, R. M., Eidne, K. A., and Pfleger, K. D. (2008) Demonstration of improvements to the bioluminescence resonance energy transfer (BRET) technology for the monitoring of G protein-coupled receptors in live cells. J Biomol Screen 13, 888–98.